Clinical Watch: July 2018

July 18, 2018

In this issue of Clinical Watch, we discuss dual therapy for overactive bladder (OAB). We suggest criteria for a new phenylketonuria (PKU) treatment and summarize and article addressing the need for proactive pharmacovigilance in identifying drugs of abuse. Lastly, we review claims data to evaluate cost and utilization trends with glucose test strips.

For more information about our solutions, please visit conduent.com/pharmacysolutions.

Previous Flipbook
Clinical Watch: August 2018
Clinical Watch: August 2018

Next Flipbook
Clinical Watch: June 2018
Clinical Watch: June 2018